TAK-861
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for TAK-861, covering 2025-01-09 to 2026-07-16. Get the full timeline:
Most recent: Clinical Trial Results: A Study of TAK-861 in People With Narcolepsy Type 1 [Phase 3]